Menu

NYT Changes Sexist Obit for Researcher

After an outcry from the Twittersphere, The New York Times alters the start of an obituary for acclaimed rocket scientist Yvonne Brill.

Apr 1, 2013
Bob Grant

YOUTUBE SCREEN SHOTNASA jet propulsion scientist Yvonne Brill, who won the prestigious National Medal of Technology and Innovation in 2011 and a Distinguished Public Service Medal in 2001 for inventing a jet propulsion system that helped keep communications satellites in their orbits, died last Wednesday (March 27). But The New York Times seemed to feel that her accomplishments as a cook and mother overshadowed her work in science, judging from the first paragraph of her obituary, published in the newspaper’s March 30 edition. The original version of the obit started like this:

“She made a mean beef stroganoff, followed her husband from job to job and took eight years off from work to raise three children. ‘The world’s best mom,’ her son Matthew said.”

This focus on her at-home skills set off a storm of angry tweets from readers after the story ran. Eventually the Times’ public editor Margaret Sullivan responded, tweeting, “To the many who've tweeted at me about the Yvonne Brill obituary, I sure agree.” The newspaper then reposted the obituary with a different lead paragraph: “She was a brilliant rocket scientist who followed her husband from job to job and took eight years off from work to raise three children. ‘The world’s best mom,’ her son Matthew said.”

Brill was a pioneering figure in the field of rocket science. She died at age 88 in Princeton, New Jersey.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.